Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $1.99, $0.05 better than the analyst estimate of $1.94. Revenue for the quarter came in at $4.49 billion versus the consensus estimate of $4.39 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.